NEW ONLINE COURSE IN BIOFILM EUROBIOFILMS 2013 Director...
Transcript of NEW ONLINE COURSE IN BIOFILM EUROBIOFILMS 2013 Director...
AV INFORMATION FOR YOUR PRESENTATION AT THE 21ST ECCMID/27TH ICC
Important points in brief:
We would like to inform you that each meeting room will be equipped with a PC and a data projector for PowerPoint presentations only. You can review your presentation at the speakers service centre (SSC), where it must be handed in at least one hour before your lecture, either via External Hard Disk, CD-Rom, memory stick, or your own laptop.
Further details and hints for computer based projections: 1. Preparation Store ALL your files in a unique folder (especially videos) Avoid animations and make sure video(s) play automatically when slide is displayed Colours: use light-coloured fonts for texts (white/yellow) on dark backgrounds or vice versa. A
strong contrast is important for good legibility Legibility check: step back 1,5 m from your computer, the text should be easily readable on
presentation mode (if not, you are using a too small font!) PowerPoint & Windows Versions from 95 to 2003 may be used
2. How to transport your MS-PowerPoint file to the Speakers Service Centre (SSC) On CD-Rom, External Hard Disk, memory stick or your own laptop
3. In the Speakers Service Centre (SSC) Please come to the SSC the day before or at least one hour before your lecture! Hostesses will be happy to welcome you in a relaxed and friendly atmosphere to help you
submit/finalise your presentation Highly experienced and skilled technicians will capture your presentation and store it on a server You then rehearse your presentation with the assistance of a technician Technicians will help you with PowerPoint and will ensure that your changes are updated on the
specific server 4. In the lecture room Via network your presentation is made available in your lecture room, on a presentation computer
operated by a technician With a touch-screen control at the lectern you can simply "ask" for the "next slide" or "previous
slide" There will be no possibility to connect your laptop at the lectern in the lecture rooms No overhead or slide projectors in the lecture rooms; no double projection No change in presentation in the lecture room by the technician or the speaker
EUROBIOFILMS 2013Third European Congress on Microbial Biofilms – Basic and Clinical Aspects
Final Programme
Ghent, Belgium, September 9-12, 2013www.eurobiofilms2013.ics.dk
www.febs.org
A FEBS Special Mee.ng organised with support from the Federa.on of European Biochemical
Socie.es
Organised and supported by ESCMID
www.biofilmcourse.ku.dk
Teachers at the course:NEW ONLINE COURSE IN BIOFILM
Director J. William CostertonCentre for Genomic Sciences, Allegheny-Singer Research Institute, USA
Assoc Prof Marvin Whiteley
In the fall of 2011 the University of Copenhagen is offering a brand new online course on “Bacterial Biofilmsand Their Role in Chronic Diseases”. The course can be followed by both Master degree and PhD students as y
Section of Molecular Genetics and Microbiology, The University of Texas at Austin, USA
Prof Matt ParsekDepartment of Microbiology, University of Washington, USA
followed by both Master degree and PhD students, as well as professionals that live up to the admission criteria. Sign up for our new biofilm online course at:
bi fil k dk Director, Phil StewartChemical and Biological Engineering, Montana State University, USA
Prof, Niels Høiby, MD, Claus Ernst Moser and Dr, Peter Østrup JensenD t t f Cli i l Mi bi l C h U i it H it l
Application deadline is 8 August 2011
www.biofilmcourse.ku.dk
Department of Clinial Microbiology, Copenhagen University Hospital, Denmark
MD, Luanne Hall-StoodleySouthampton Wellcome Trust Clinical Research Facility and University of Southampton Respiratory BRU, Southampton General Hospital, UK
Prof Michael Givskov, Assoc Prof Tim Tolker-Nielsen and Assoc Prof, Thomas BjarnsholtFaculty of Health Sciences, University of Copenhagen, Denmark
Prof, Søren MolinDepartment for Systems Biology, Technical University of Denmark
Table of Contents
Welcome Message . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Organisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Programme Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Scientific Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6Information to Presenters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11Sponsors and Support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12Social Programme. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12General Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13Poster Line Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
EUROBIOFILMS 2013 · 3
Organisation
Organising Committee: Tom Coenye (president), Patrick Van Dijck (vice-president) and the ESGB Executive Committee
International Scientific Advisory Board: Nico Boon (BE), Oana Ciofu (DK), Irene Dige (DK), Gianfranco Donelli (IT), Max Dow (IRL), Hans Curt Flemming (DE), Christine Imbert (FR), Mary-Ann Jabra-Rizk (US), Katrien Lagrou (BE), José Lopez-Ribot (US), Satoshi Okabe (JP), Lakshman Samaranayake (HK), Dirk Springael (BE), W. Edward Swords (US), Karin Thevissen (BE), Hennie van der Mei (NL), Laurence Van Melderen (BE), Jeremy Webb (UK), Thomas Wood (US).
ESGB (ESCMID Study Group for Bio-films) Executive Committee : Thomas Bjarnsholt (DK, chairperson), Tom Coenye (BE, vice chairperson), Christine Imbert (FR, secretary), Craig Williams (UK, treasurer), Veronika Hola (CZ), Antonio Oliver (ES), Niels Hoiby (DK), Gianfranco Donelli (IT), Johan Van Eldere (BE)
Congress Secretariat
International Conference ServicesP.O. Box 41
Strandvejen 169-171DK-2900 Hellerup, Copenhagen
Denmark
Tel: +45 7023 5056
E-mail: [email protected] Web: www.eurobiofilms2013.ics.dk
Web: www.ics.dk
Welcome Message
On behalf of the Organising Committee and the ESCMID Study Group for Biofilms (ESGB) it is our great pleasure to welcome you to “Eurobiofilms 2013” in Ghent. After the very successful Eurobiofilms meetings in Rome (September 2009) and Copenhagen (July 2011), this is the third biannual meeting organised by the ESGB.
It is clear from the number of submitted abstracts and registered participants that microbial biofilms continue to be a hot topic among microbiologists. This conference will cover both basic and clinical aspects of bacterial and fungal biofilms and we are convinced you will be impressed with the level and the diversity of the research that will be presented during these four days.
Despite the busy program, we hope that you will find some time to catch up with old friends and/or make some new friends. You will see that the wonderful city of Ghent presents itself with ample opportunities to do so!
Finally, we would like to thank the Federation of European Biochemical Societies (FEBS), the Research Foundation – Flanders, the Belgian Science Policy Office, the Faculty of Pharmaceutical Sciences of Ghent University and VIB for their support. In addition, support from ESCMID has allowed us to provide attendance grants to 14 participants. Without these partners the organisation of this meeting would not have been possible.
Tom Coenye Patrick Van Dijck
4 · Ghent, Belgium, September 9-12, 2013
Programme Overview
TIME MONDAY 9 SEPTEMBER TUESDAY 10 SEPTEMBER WEDNESDAY 11 SEPTEMBER THURSDAY 12 SEPTEMBER
8:15 Parallel session 09: Indirect pathogenicity and the role of mixed species biofilms in infections
Room Aula
Parallel session 10: Biofilms put to work: application of microbial biofilms in various processes
Room ARZ
8:30
8:45
9:00 Workshop 1 - Identification and visualisation of biofilm-associated micro-organisms
Room Aula
Workshop 2 - Animal models for studying biofilms
Room ARZ
Keynote lectures
Keynote lectures
Room Aula
9:15
9:30
9:45
10:00 Coffee Break Coffee Break
10:15 Coffee break Final joint symposium: Signalling in microbial biofilms : c-di-GMP, quorum sensing and beyond
Room Aula
10:30 Parallel session 05: Heterogeneity and evolution in biofilms
Room Aula
Parallel session 06: Medical device-related biofilm infections and modified materials
Room ARZ
10:45 Parallel session 01: Clinical relevance of fungal biofilms
Room Aula
Parallel session 02: Toxin-antitoxin systems and persister cells in microbial biofilms
Room ARZ
11:00
11:15
11:30
11:45 Poster awards and Closing of Eurobiofilms 2013Room Aula12:00 Lunch Break
12:15
12:30 Lunch Break Lunch Break
12:45 Workshop 1 - Identification and visualisation of biofilm-associated micro-organisms cont.
Workshop 2 - Animal models for studying biofilms cont.
13:00 Poster session 01 Poster session 02
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00 Parallel session 03: Mechanism of biofilm resistance and tolerance
Room Aula
Parallel session 04: Oral biofilms
Room ARZ
Parallel session 07: Fundamental aspects of fungal biofilm formation and resistance
Room ARZ
Parallel session 08: Ecology of aquatic biofilms
Room Aula
15:15
15:30
15:45
16:00
16:15
16:30
16:45 Special session
Room ARZ
17:00
17:15
17:30 Opening and welcome addresses
Room Aula
17:45
18:00
18:15
18:30
19.00 Opening reception (Het Pand)
Room Aula
EUROBIOFILMS 2013 · 5
TIME MONDAY 9 SEPTEMBER TUESDAY 10 SEPTEMBER WEDNESDAY 11 SEPTEMBER THURSDAY 12 SEPTEMBER
8:15 Parallel session 09: Indirect pathogenicity and the role of mixed species biofilms in infections
Room Aula
Parallel session 10: Biofilms put to work: application of microbial biofilms in various processes
Room ARZ
8:30
8:45
9:00 Workshop 1 - Identification and visualisation of biofilm-associated micro-organisms
Room Aula
Workshop 2 - Animal models for studying biofilms
Room ARZ
Keynote lectures
Keynote lectures
Room Aula
9:15
9:30
9:45
10:00 Coffee Break Coffee Break
10:15 Coffee break Final joint symposium: Signalling in microbial biofilms : c-di-GMP, quorum sensing and beyond
Room Aula
10:30 Parallel session 05: Heterogeneity and evolution in biofilms
Room Aula
Parallel session 06: Medical device-related biofilm infections and modified materials
Room ARZ
10:45 Parallel session 01: Clinical relevance of fungal biofilms
Room Aula
Parallel session 02: Toxin-antitoxin systems and persister cells in microbial biofilms
Room ARZ
11:00
11:15
11:30
11:45 Poster awards and Closing of Eurobiofilms 2013Room Aula12:00 Lunch Break
12:15
12:30 Lunch Break Lunch Break
12:45 Workshop 1 - Identification and visualisation of biofilm-associated micro-organisms cont.
Workshop 2 - Animal models for studying biofilms cont.
13:00 Poster session 01 Poster session 02
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00 Parallel session 03: Mechanism of biofilm resistance and tolerance
Room Aula
Parallel session 04: Oral biofilms
Room ARZ
Parallel session 07: Fundamental aspects of fungal biofilm formation and resistance
Room ARZ
Parallel session 08: Ecology of aquatic biofilms
Room Aula
15:15
15:30
15:45
16:00
16:15
16:30
16:45 Special session
Room ARZ
17:00
17:15
17:30 Opening and welcome addresses
Room Aula
17:45
18:00
18:15
18:30
19.00 Opening reception (Het Pand)
6 · Ghent, Belgium, September 9-12, 2013
Scientific Programme
MONDAY 9 SEPTEMBER 2013
From 08h30 Registration
17h20 Welcome address and opening of the conference (Tom Coenye, Belgium) (Aula)
17h50 – 18h40 Opening lecture by Phil Stewart (CBE, Bozeman, MT, USA): Engineering Science of Biofilm Control (Aula)
19h00 – 20h30 Opening reception (Het Pand)
TUESDAY 10 SEPTEMBER 2013
From 08h15 Registration and poster set-up
09h00 – 10h00 Keynote lectures (chaired by Patrick Van Dijck & Tom Coenye) (Aula)
09h00 – 09h30 KL0101 - Fungal-Bacterial Interactions: Clinical Implications and Therapeutic Measures, Mary-Ann Jabra-Rizk (University of Maryland, Baltimore, MD, USA)
09h30 – 10h00 KL0102 - Microenvironmental analysis of biofilms, Michael Kühl (University of Copenhagen, Copenhagen, Denmark)
10h00 – 10h15 Introduction of the ”Pathogens & Disease” thematic issue on biofilms, Patrik Bavoil (University of Maryland, Baltimore, MD, USA)
10h15 – 10h40 Coffee break (Peristilium)
10h40 – 12h30 Parallel sessions
Clinical relevance of fungal biofilms (chaired by Katrien Lagrou & Christine Imbert) (Aula)10h40 – 11h10 PS0101 - Clinical Importance of Fungal Biofilms, Katrien Lagrou (Belgium)
11h10 – 11h40 PS0102 - Direct and indirect involvement of Candida biofilms in clinical settings, Christine Imbert (France)
11h40 – 11h55 PS0103 - The prevalence of the selected genes involved in biofilm formation in Candida albicans isolated from the oral cavity (Jolanta Szymanska, Poland)
11h55 – 12h10 PS0104 - Nicotinic acid limitation promotes Candida glabrata adherence to denture acrylic surfaces (Dongmei Deng, The Netherlands)
12h10 – 12h25 PS0105 - The plant-derived decapeptide OSIP108 inhibits Candida albicans biofilm formation with out affecting cell viability (Nicholas Delattin, Belgium)
Toxin-antitoxin systems and persister cells in microbial biofilms (chaired by Laurence Van Melderen & Thomas Wood) (ARZ)10h40 – 11h05 PS0201 - Bacterial toxin-antitoxin systems: why so many, what for?, Laurence Van Melderen (Belgium)
11h05 – 11h30 PS0202 - Toxin GhoT of the Novel Type V Toxin/Antitoxin System GhoT/GhoS Decreases ATP Production at the Poles, Thomas Wood (USA)
11h30 – 11h45 PS0203 - Structural basis of Shewanella oneidensis MR-1 HipAB with its operator DNA reveals new insight in persister mechanism (Yurong Wen, Belgium)
11h45 – 12h00 PS0204 - Involvement of toxin antitoxin modules in tolerance of Burkholderia cenocepacia biofilms (Heleen Van Acker, Belgium)
EUROBIOFILMS 2013 · 7
12h00 – 12h15 PS0205 In situ identification of persisters by visualizing Z-ring formation (Shinya Matsumoto, Japan)
12h15 – 12h30 PS0206 - Small colony variants in biofilm population is not strictly required for biofilm resistance and persistence (Ana Margarida Sousa, Portugal)
12h30 – 13h00 Lunch break (Peristilium)
13h00 – 15h00 Poster session I (Peristilium)
15h00 – 17h00 Parallel sessions
Mechanism of biofilm resistance and tolerance (chaired by Karin Thevissen & Oana Ciofu) (Aula)15h00 – 15h25 PS0301 - Repurposing as a means to increase the activity of Amphotericin B and Caspofungin against Candida albicans biofilms, Karin Thevissen (Belgium)
15h25 – 15h50 PS0302 - Treatment of P. aeruginosa biofilm infection: the basis of current recommendations and future perspectives, Oana Ciofu (Denmark)
15h50 – 16h05 PS0303 - Deciphering genetic traits of the biocide hyper-tolerance of biofilms formed by a medical Bacillus subtilis isolate (Maria Del Pilar Sanchez Vizuete, France)
16h05 – 16h20 PS0304 - eDNA impedes vancomycin penetration in pre-exposed sub-MIC vancomycin biofilms (Natalya Doroshenko, UK)
16h20 – 16h35 PS0305 - Anti-biofilm activity of atmospheric pressure cold plasmas: efficacy and mechanism (Brendan Gilmore, UK)
16h35 – 16h50 PS0306 - Polymorphonuclear leukocytes restrict the growth of Pseudomonas aeruginosa in lungs of cystic fibrosis patients (Kasper Norskov Kragh, Denmark)
Oral biofilms (chaired by Irene Dige & Lakshman Samaranayake) (ARZ)15h00 – 15h25 PS0401 - Molecular methods for studies of the architecture of intact biofilm in caries, Irene Dige (Denmark)
15h25 – 15h50 PS0402 - Candida in polymicrobial biofilms, Lakshman Samaranayake (Hong Kong)
15h50 – 16h05 PS0403 - The role of fungi in a healthy oral ecology (Bastiaan Krom, The Netherlands)
16h05 – 16h20 PS0404 - Removal of oral biofilms by a marine microbial deoxyribonuclease (Robert Shields, UK)
16h20 – 16h35 PS0405 - The role of DPPIV as a virulence factor for Porphyromonas gingivalis infections (Sofie Clais, Belgium)
16h35 – 16h50 PS0406 - Osteopontin-containing calcium phosphate nanoparticle aggregates – A new therapeutic approach to caries control (Sebastian Schlafer, Denmark)
8 · Ghent, Belgium, September 9-12, 2013
WEDNESDAY 11 SEPTEMBER 2013
From 08h30 Registration and poster set-up
09h00 – 10h00 Keynote lectures (chaired by Patrick Van Dijck & Tom Coenye) (Aula)
09h00 – 09h30 KL0201 - Microbial biofilms & chronic wounds, Thomas Bjarnsholt (University of Copenhagen, Copenhagen, Denmark)
09h30 – 10h00 KL0202 - Unraveling the transcriptional network controlling biofilm development in Candida albicans, Clarissa Nobile (University of California, San Francisco, CA, USA)
10h00 – 10h30 Coffee break (Peristilium)
10h30 – 12h30 Parallel sessions
Heterogeneity and evolution in biofilms (chaired by Jeremy Webb & Tom Coenye) (Aula)10h30 – 11h00 PS0501 - Population ecology of persister cells in biofilms, Jeremy Webb (UK)
11h00 – 11h15 PS0502 - Experimental evolution: an approach to understand the mode of action of a biofilm inhibi-tor (Akanksha Dubey, Belgium)
11h15 – 11h30 PS0503 - Heterogonous transcription of genetic elements in biofilm of Salmonella in response to different stress conditions (Dov Schlisselberg, Israel)
11h30 – 11h45 PS0504 - Protease secretion of Staphylococcus epidermidis and the effect of S. epidermidis superna-tant on Staphylococcus aureus biofilms (Ilse Vandecandelaere, Belgium)
11h45 – 12h00 PS0505 - Biofilm competition and coexistence – a dual species biofilm model (Saravanan Periasamy, Singapore)
12h00 – 12h15 PS0506 - Synergistic interactions within polymicrobial biofilms formed by atypical and conventional species in cystic fibrosis (Susana Patrícia Peixoto Lopes, Portugal)
Medical device-related biofilm infections and modified materials (chaired by Hennie van der Mei & Gianfranco Donelli) (ARZ)10h30 – 10h55 PS0601 - Biofilm-based urinary catheter-associated infections, Gianfranco Donelli (Italy)
10h55 – 11h20 PS0602 - New Strategies to Fight against Biomaterial Associated Infections, Hennie van der Mei (The Netherlands)
11h20 – 11h35 PS0603 - COATIM – Development of antibiofilm coatings for implants (Katrijn De Brucker, Belgium)
11h35 – 11h50 PS0604 - Bacterial biofilm formation and treatment in soft tissue fillers (Morten Alhede, Denmark)
11h50 – 12h05 PS0605 - Interaction between non-disease causing microorganism and E. coli in catheter-associated urinary tract biofilms (Andreia Azevedo, Portugal)
12h05 – 12h20 PS0606 - Polymicrobial biofilm dynamics during catheter-associated urinary tract infections (Sharon Goh, Singapore)
12h30 – 13h00 Lunch break (Peristilium)
13h00 – 15h00 Poster session II (Peristilium)
EUROBIOFILMS 2013 · 9
15h00 – 17h00 Parallel sessions
Fundamental aspects of fungal biofilm formation and resistance (chaired by Patrick Van Dijck & José Lopez-Ribot) (ARZ)15h00 – 15h25 PS0701 - Novel tools to study biofilm formation in live animals and Als3 peptides as novel antibiofilm molecules, Patrick Van Dijck (Belgium)
15h25 – 15h50 PS0702 - Targeting Biofilm Formation for Antifungal Drug Development, José Lopez-Ribot (USA)
15h50 – 16h05 PS0703 - Transcriptional regulation of Candida albicans biofilm development over time (Emily Fox, USA)
16h05 – 16h20 PS0704 - Antifungal activity of cathelicidin peptides against planktonic cultures and biofilms of pathogenic Candida species (Michele Scarsini, Italy)
16h20 – 16h35 PS0705 - Effect of alkylphospholipids on Candida spp. biofilm formation and maturation (Taissa Vila, Brazil)
Ecology of aquatic biofilms (chaired by Nico Boon & Hans Curt Flemming) (Aula)15h00 – 15h30 PS0801 - Pathogens in drinking water biofilms – hide and seek, Hans Curt Flemming (Germany)
15h30 – 15h45 PS0802 - Bacterial diversity of biofilms in UK drinking water networks: implications for water quality (Isabel Douterelo, UK)
15h45 – 16h00 PS0803 - Passage through amoeba induces Legionella pneumophila biofilm production (Renaud Bigot, France)
16h00 – 16h15 PS0804 - Extracellular DNA in aquatic biofilms: a universal adhesin (Rikke Louise Meyer, Denmark)
16h15 – 16h30 PS0805 - Biofouling of reverse osmosis membranes after tertiary wastewater desalination: microbial community composition (Ashraf Ashhab, Israel)
16h45 – 17h45 Special session (chaired by Tom Coenye & Thomas Bjarnsholt) (ARZ)
SS0101 - The BioFomics Database/MIABiE project (Nuno Azevedo, Portugal)
SS0102 -Consensus guidelines on diagnosis and treatment of biofilm infections (Niels Hoiby, Denmark)
THURSDAY 12 SEPTEMBER 2013
From 08h15 Registration
08h15 –09h55 Parallel sessions
Indirect pathogenicity and the role of mixed species biofilms in infections (chaired by W. Edward Swords & Mary-Ann Jabra-Rizk) (Aula)08h15 – 08h40 PS0901 - Polymicrobial biofilms in otitis media, W. Edwards Swords (USA)
08h40 – 08h55 PS0902 - Use of an in vitro gut model to study biofilm mode of growth of Clostridium difficile and indigenous gut microbiota (Grace Crowther, UK)
08h55 – 09h10 PS0903 - Polymicrobial interactions in multispecies biofilms of cystic fibrosis pathogens, Pseudomo-nas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cenocepacia in a drip flow reactor (Indra Sandal, USA)
10 · Ghent, Belgium, September 9-12, 2013
09h10 – 09h25 PS0904 - Phagocytosis of Candida albicans-adhered Staphylococcus aureus (Nina Scheres, The Netherlands)
09h25 – 09h40 PS0905 - Exploring the influence of Candida albicans and Staphylococcus aureus on the resistance of Pseudomonas aeruginosa biofilms towards disinfectants and antibiotics (Sarah Tavernier, Belgium)
09h40 – 09h55 PS0906 - Biofilm dispersal - bench to bedside (Jeremy Webb, UK)
Biofilms put to work : application of microbial biofilms in various processes (chaired by Dirk Springael & Michael Kühl) (AZR)08h15 – 08h45 PS1001 - Biofilms for treatment of pesticide residue contaminated drinking water or doing your job
on an empty stomach, Dirk Springael (Belgium)
08h45 – 09h00 PS1002 – Exploring the molecular mechanisms of aggregation in cyanobacteria, (Esther Karunakaran, UK)
09h00 – 09h15 PS1003 - Effect of electrochemical potential on biosynthesis of silver nanoparticles in Shewanella oneidensis MR-1 biofilm (Michael Kitching, Ireland)
09h15 – 09h30 PS1004 - Cross-species metabolism of natural dissolved organic carbon enhances the synergistic removal of xenobiotics (Benjamin Horemans, Belgium)
09h30 – 09h45 PS1005 - Harnessing oil sands microbes as biofilms for bioremediation (Marc Demeter, Canada)
09h45 – 10h15 Coffee break (Peristilium)
10h15 – 11h40 Final joint symposium
Signalling in microbial biofilms : c-di-GMP, quorum sensing and beyond (chaired by Tom Coenye & Max Dow) (Aula)10h15 – 10h40 JS0101 - Cyclic di-GMP as a second messenger in the regulation of biofilm formation and virulence
by cell-cell signalling in Xanthomonas, Max Dow (Ireland)
10h40 – 10h55 JS0102 - Tampering with purine and pyrimidine biosynthesis modulates biofilm formation of Escherichia coli and Salmonella (Anna Yssel, Belgium)
10h55 – 11h10 JS0103 - Are amyloids the information superhighways of biofilms? (Thomas Seviour, Singapore)
11h10 – 11h25 JS0104 - DSF family signal molecules found in the cystic fibrosis airway modulate biofilm formation and antibiotic tolerance in Pseudomonas aeruginosa (Kate Twomey, Ireland)
11h25 – 11h40 JS0105 - Dispersion induced by cell-to-cell communication signaling molecule in Pseudomonas aeruginosa biofilm (Satoshi Ito, Japan)
11h40 – 12h00 Poster awards – closing (Aula)
12h00 End of conference (lunch boxes will be provided)
EUROBIOFILMS 2013 · 11
Oral presentationsBoth conference rooms are equipped with a PC and LCD projector. Presenters are advised to bring their presenta-tion (in powerpoint or pdf format) on a USB device and should identify themselves to the chairperson of their session in the break preceding their session the latest. Al-though laptop computers can be connected to the system, use of your own computer is strongly discouraged and presenters will be responsible to make sure that their com-puter can be connected. Mac users are required to bring all necessary adaptors to hook their computer up to the projection system.
• Speakers are requested to present themselves to the chair in the lecture room 10 minutes prior to the beginning of their session
• Please respect the time limits. Each topic is sched-uled to last for 15 minutes, which means approx. 10 minutes for the presentation leaving 5 minutes for questions. The moderator is responsible for the time table and will interrupt if a presentation ex-tends beyond the allocated time.
Poster presentationsPosters 1 to 107 should be mounted on Tuesday morn-ing and will be presented during the first poster session (Tuesday from 13.00 to 15.00). These posters need to be removed after the final session on Tuesday.
Posters 108 to 204 should be mounted on Wednesday morning and will be presented during the second poster session (Wednesday from 13.00 to 15.00). These posters need to be removed after the final session on Wednesday.
Material to mount your poster will be provided.
Posters that will not be removed at the end of the session will be removed by the organisers, who cannot be held responsible for damage to posters.
Information to Presenters
Sponsors and Support
With additional support from
Organised and supported by ESCMID A FEBS Special Meeting organised with support from the Federation of European Biochemical Societies
www.febs.org
A FEBS Special Mee.ng organised with support from the Federa.on of European Biochemical
Socie.es
Organised and supported by ESCMID
With addi.onal support from
With addi.onal support from
With addi.onal support from
AV INFORMATION FOR YOUR PRESENTATION AT THE 21ST ECCMID/27TH ICC
Important points in brief:
We would like to inform you that each meeting room will be equipped with a PC and a data projector for PowerPoint presentations only. You can review your presentation at the speakers service centre (SSC), where it must be handed in at least one hour before your lecture, either via External Hard Disk, CD-Rom, memory stick, or your own laptop.
Further details and hints for computer based projections: 1. Preparation Store ALL your files in a unique folder (especially videos) Avoid animations and make sure video(s) play automatically when slide is displayed Colours: use light-coloured fonts for texts (white/yellow) on dark backgrounds or vice versa. A
strong contrast is important for good legibility Legibility check: step back 1,5 m from your computer, the text should be easily readable on
presentation mode (if not, you are using a too small font!) PowerPoint & Windows Versions from 95 to 2003 may be used
2. How to transport your MS-PowerPoint file to the Speakers Service Centre (SSC) On CD-Rom, External Hard Disk, memory stick or your own laptop
3. In the Speakers Service Centre (SSC) Please come to the SSC the day before or at least one hour before your lecture! Hostesses will be happy to welcome you in a relaxed and friendly atmosphere to help you
submit/finalise your presentation Highly experienced and skilled technicians will capture your presentation and store it on a server You then rehearse your presentation with the assistance of a technician Technicians will help you with PowerPoint and will ensure that your changes are updated on the
specific server 4. In the lecture room Via network your presentation is made available in your lecture room, on a presentation computer
operated by a technician With a touch-screen control at the lectern you can simply "ask" for the "next slide" or "previous
slide" There will be no possibility to connect your laptop at the lectern in the lecture rooms No overhead or slide projectors in the lecture rooms; no double projection No change in presentation in the lecture room by the technician or the speaker
www.biofilmcourse.ku.dk
Teachers at the course:NEW ONLINE COURSE IN BIOFILM
Director J. William CostertonCentre for Genomic Sciences, Allegheny-Singer Research Institute, USA
Assoc Prof Marvin Whiteley
In the fall of 2011 the University of Copenhagen is offering a brand new online course on “Bacterial Biofilmsand Their Role in Chronic Diseases”. The course can be followed by both Master degree and PhD students as y
Section of Molecular Genetics and Microbiology, The University of Texas at Austin, USA
Prof Matt ParsekDepartment of Microbiology, University of Washington, USA
followed by both Master degree and PhD students, as well as professionals that live up to the admission criteria. Sign up for our new biofilm online course at:
bi fil k dk Director, Phil StewartChemical and Biological Engineering, Montana State University, USA
Prof, Niels Høiby, MD, Claus Ernst Moser and Dr, Peter Østrup JensenD t t f Cli i l Mi bi l C h U i it H it l
Application deadline is 8 August 2011
www.biofilmcourse.ku.dk
Department of Clinial Microbiology, Copenhagen University Hospital, Denmark
MD, Luanne Hall-StoodleySouthampton Wellcome Trust Clinical Research Facility and University of Southampton Respiratory BRU, Southampton General Hospital, UK
Prof Michael Givskov, Assoc Prof Tim Tolker-Nielsen and Assoc Prof, Thomas BjarnsholtFaculty of Health Sciences, University of Copenhagen, Denmark
Prof, Søren MolinDepartment for Systems Biology, Technical University of Denmark
12 · Ghent, Belgium, September 9-12, 2013
Registration fees onsite:Regular participants € 700Pre-graduates € 475
EntitlementsDelegates’ registration includes:Participation in the Scientific Programme.Final Programme Coffee and Lunch Breaks Opening Reception
Registration & information deskOpening hours:Monday, 9 September 8.30-10.00/14.00-20.30 Tuesday, 10 September 8.15-17.00Wednesday, 11 September 8.30-17.00Thursday, 12 September 8.15-12.00
Cancellation & Refund PolicyCredit can not be given for unattended events, late arriv-als or early departure. All refunds will be processed after the Congress.
Registration
Social Programme
Opening Reception, 9 September 2013, 19h00-20h30Come join your colleagues for an informal Opening Reception the evening before the first day of the official congress programme. The event will take place at Ghent University’s Culture and Convention Center Het Pand, a beautiful building established as a Dominican monastery around 1228 and located in the city center.
Address: Het PandOnderbergen 1Ghent
Participation is included in the registration fee
Het Pand
EUROBIOFILMS 2013 · 13
General Information
Congress venueGhent University Aula is located within walking distance from all hotels in Ghent.
Address: Ghent University AulaVoldersstraat 9GhentBelgiumTel: +45 70 23 50 56 (Congress Secretariat)
In 1816, the Dutch administration chose Ghent as founding place for a higher education institute. Simultaneously, the city council felt it needed a building to host official festivities and decided to construct the Aula Academica in the city centre. The then unknown architect Louis Roelandt was appointed to design it. The first stone was laid in 1819 and the building was inaugurated in 1826.
Nowadays the heart of the Ghent University beats in the Aula. Here, the students receive their diploma, diverse colloquia and debates are organised, and numerous prominent people are entertained and honoured. The Aula is used as the logo of the Ghent University and, as such, truly symbolises the Alma Mater.
Wireless internet connection at the conference venueWireless internet will be available through the Eduroam world-wide roaming access service developed for the international research and education community. This is only available for staff and students from participating institutions. Once inside the conference venue you follow your university or institution’s logon procedure. The settings at Ghent University are as follows: SSID: eduroamSecurity type: WPA2Encryption Type: AES
Information on the internet aboutThe Congress: www.eurobiofilms2013.ics.dkVisit Gent: www.visitgent.beThe weather in Belgium: www.meteo.be Ghent University: www.ugent.be
TransportationBrussels Airport: www.brusselsairport.be/ Trains: www.belgianrail.beTravel to Ghent: www.visitgent.be/en/how-get-ghent
LanguageThe official language of EUROBIOFILMS 2013 is English.No translations will be provided.
Name badgeEntrance to the sessions will be limited to badge holders only. If the badge is lost, please contact the Registration Desk. A fee of € 7 will be charged for each new badge.
InsuranceYou are requested to arrange your own health and travel insurance. The congress organiser is not able to take responsibility for any injuries or damages that may occur during the congress.
Currency & credit cardsThe currency in Belgium is the EURO. Major credit cards are accepted in hotels, restaurants and shops. Should you wish to use your credit card to pay a taxi, please inform the driver immediately when you step in.
Het Pand
14 · Ghent, Belgium, September 9-12, 2013
POSTER SESSION 01 - TUESDAY 10 SEPTEMBER, 13:00 – 15:00
PARAllEl SESSION 01 - ClINICAl RElEvANCE OF FUNGAl BIOFIlMS
PE01 The prevalence of the selected genes involved in biofilm formation in C. albicans isolated from the oral cavityJolanta Szymańska (POLAND), A Kamińska, A Malm
PE02 Nicotinic acid limitation promotes Candida glabrata adherence to denture acrylic surfacesDongmei Deng (THE NETHERLANDS), B Krom, W Crielaard, Hd Soet
PE03 The plant-derived decapeptide OSIP108 inhibits Candida albicans biofilm formation without affecting cell viability
Nicolas Delattin (BELGIUM), K De Brucker, D Craik, O Cheneval, T Davis, C Kumamoto, P Cos, B De Coninck, B Cammue, K Thevissen
PE04 Precoating of medical-grade silicone with Lactobacillus biosurfactant inhibits biofilm formation of Candida albicansC Ceresa, Francesco Tessarolo (ITALY), F Piccoli, I Caola, G Nollo, M Cavallo, L Fracchia
PE05 Inhibition of Candida albicans Biofilm by Lipopeptide Biosurfactant AC7 and its Synergistic Effect with Amphotericin B and FarnesolChiara Ceresa (ITALY), L Goemaere, E Willem, M Cavallo, L Fracchia
PE06 The synthetic Amphipathic Peptidomimetic lTX109 is a potent Fungicide that disturbs plasma membrane integrity in a Sphingolipid dependent mannerCamilla Eggert Larsen (DENMARK), R Bojsen, R Torbensen, A Folkesson, B Regenberg
PARAllEl SESSION 02 - TOXIN-ANTITOXIN SYSTEMS AND PERSISTER CEllS IN MICROBIAl BIOFIlMS
PE07 Structural Basis of Shewanella Oneidensis MR-1 HipAB with its Operator DNA Reveals New Insight in Persister MechanismYurong Wen (BELGIUM), E Behiels, J Felix, B Vergauwen, B Devreese, S Savvides
PE08 Involvement of toxin antitoxin modules in tolerance of Burkholderia cenocepacia biofilmsHeleen Van Acker (BELGIUM), H Nelis, T Coenye
PE09 In situ identification of persisters by visualizing Z-ring formationShinya Matsumoto (JAPAN), S Miyagawa, Y Iwamoto, S Tsuneda
PE10 Small colony variants in biofilm population is not strictly required for biofilm resistance and persistenceAna Margarida Sousa (PORTUGAL), A Rodrigues, MO Pereira
PE11 Regulation of toxin-antitoxin systems under stress conditions inducing persistence in Escherichia coliSophie Le Blastier (BELGIUM), L Van Melderen
PARAllEl SESSION 03 - MECHANISM OF BIOFIlM RESISTANCE AND TOlERANCE
PE12 Deciphering genetic traits of the biocide hyper-tolerance of biofilms formed by a medical Bacillus subtilis isolateMaria Del Pilar Sanchez Vizuete (FRANCE), A Bridier, F DubFlorence ois-Brissonnet, S Aymerich, D Le Coq, R Briandet
Poster Line Up
Tuesd
ay 10
Sep
temb
er
EUROBIOFILMS 2013 · 15
PE13 eDNA impedes vancomycin penetration in pre-exposed sub-MIC vancomycin biofilmsNatalya Doroshenko (UNITED KINGDOM), BS Tseng, Mr Parsek, J Wharton, P Thurner, P Stoodley
PE14 Anti-biofilm Activity of Atmospheric Pressure Cold Plasmas: Efficacy and MechanismM Alkawareek, S Gorman, W Graham, Brendan Gilmore (UNITED KINGDOM)
PE15 Polymorphonuclear leukocytes restrict the Growth of Pseudomonas aeruginosa in lungs of Cystic Fibrosis PatientsKasper Nørskov Kragh (DENMARK), M Alhede, PØ Jensen, C Moser, CS Jacobsen, SS Poulsen, SR Eickhardt-Sørensen, H-P Hougen, M Givskov, M Kühl, N Høiby, T Bjarnsholt
PE16 Antibiofilm activity and mechanism of action of Imidazolium ionic liquidsKiran Kumar Reddy. G (INDIA), Nancharaiah Y V, Venugopalan V P
PE17 Biofilm-forming XDR vs MDR Klebsiella pneumoniae clinical isolatesClaudia Vuotto (ITALY), F Longo, G Donelli, MP Balice, A Salvia, PE Varaldo
PE18 Biofilm-forming A.baumannii strains and response to carbapenemsFrancesca Longo (ITALY), C Vuotto, M Barros, F Grosso, L Peixe, G Donelli
PE19 Matrix components provide protection against tobramycin in Burkholderia cepacia complex biofilmsAnne-Sophie Messiaen (BELGIUM), H Nelis, T Coenye
PE20 Activity of DOXP pathway inhibitors against planktonic and sessile cells of various multidrug resistant bacteria.Annelien Everaert (BELGIUM), R Chofor, S Van Calenbergh, T Coenye
PE21 Deciphering genetic traits of the biocide hyper-tolerance of biofilms formed by a medical Bacillus subtilis isolateMaria Del Pilar Sanchez Vizuete (FRANCE), A Bridier, F DubFlorence ois-Brissonnet, S Aymerich, D Le Coq, R Briandet
PE22 Sub-inhibitory concentrations of antibiotics and wastewater influencing biofilm formation and gene expression of multi-resistant Pseudomonas aeruginosa wastewater isolatesJulia Bruchmann (GERMANY), S Kirchen, T Schwartz
PE23 Assessing the resistance of bacterial biofilms formed on microtitre plates towards two disinfectantsKhadidja Medjahdi (ALGERIA), A Cherif-antar, H Beldjilali, N Didouh, B Moussa-Boudjemaa
PE24 The Effect of Plasmids and Other Biomolecules on the Effectiveness of Antibiofilm AgentsLuciana Gomes (PORTUGAL), PA Araújo, JS Teodósio, M Simões, FJ Mergulhão
PE25 Antiseptics and antibiotics- their effect against S. aureus in biofilmLene K Vestby (NORWAY), KCS Johannesen, LL Nesse
PE26 The effect of polyamines on biofilm formation by Salmonella and E. coliLive L. Nesse (NORWAY), K Berg, LK Vestby
PE27 Study of biofilms from a Gram-negative multi-drug resistant pathogen in a non-animal infection model.Gabriel Benthall (UNITED KINGDOM), M Sutton, M Wand
PE28 Revealing moxifloxacin activity against biofilms of S. aureus isolated from persistent infections by means of positively-charged substancesWafi Siala (BELGIUM), M-P Mingeot-Leclercq, PM Tulkens, F Van Bambeke
PE29 Biofilm formation by bovine coagulase-negative Staphylococcal isolatesMario Jacques (CANADA), Y.D.N. Tremblay, D Lamarche, A Blondeau, V Caron, P Chever, D Haine, S Messier
Tues
day
10
Sep
tem
ber
16 · Ghent, Belgium, September 9-12, 2013
PE30 Kinetics of antimicrobial effects on biofilms measured by turbidity and propidium-iodide fluorescence
Rune Skjåstad (NORWAY), H Wiker, V Bakken
PE31 Effect of pH and surface proteins on biofilm formation of Lactobacillus plantarumNika Koyama (JAPAN), K Kakihara, N Obana, H Kubota, T Kiyokawa, I Kawashima, K Hosoya, H Tokuda, N Nomura
PE32 Biofilm formation of Clostridium perfringens following exposition to antimicrobials and anticoccidials
Audrey Charlebois (CANADA), M Jacques, M Archambault
PARAllEl SESSION 04 - ORAl BIOFIlMS
PE33 The role of fungi in a healthy oral ecologyBastiaan Krom (THE NETHERLANDS), W Crielaard, B ten Cate
PE34 Removal of Oral Biofilms by a Marine Microbial DeoxyribonucleaseRobert Shields (UNITED KINGDOM), M Hall, M Reda ElBadawey, G Burgess, N Jakubovics
PE35 The role of DPPIv as a virulence factor for P. gingivalis infectionsSofie Clais (BELGIUM), M Kerstens, T Horemans, W Teughels, M Quirynen, I De Meester, AM Lambeir, G Boulet, P Delputte, L Maes, P Cos
PE36 Osteopontin-containing calcium phosphate nanoparticle aggregates – A new therapeutic approach to caries control.
Sebastian Schlafer (DENMARK), J Olsen, H Birkedal, B Nyvad, R Meyer
PE37 Development of an Enterococcus faecalis GFP biofilm susceptibility assayMichel Hoogenkamp (THE NETHERLANDS), W Crielaard, B Krom
PE38 Effects of different plaque and saliva donors on oral microcosms in vitroMercedes Fernandez Y Mostajo (THE NETHERLANDS), R Exterkate, E Zaura, W Crielaard
PE39 S. mutans - C. albicans interactions in early childhood cariesMarjoleine Willems (THE NETHERLANDS), H Li, MA Jabra-Rizk, B Krom
PE40 Phenotypic differentiation of oral biofilmsMarleen Janus (THE NETHERLANDS), M Fernandez y Mostajo, R Exterkate, W Crielaard, B Krom
PE41 The microbial composition of supragingival biofilms during development in young healthy adults in correlation to experimentally induced gingivitisDaniela Langfeldt (GERMANY), SC Neulinger, J Eberhard, RA Schmitz
PE42 The anti-biofilm activity of cell products of probiotic Lactobacillus strainsVeronika Hola (CZECH REPUBLIC), F Ruzicka, A Cechalova
PE43 The usefulness of ingestion of raspberries to prevent oral Candida biofilmsMarion Girardot (FRANCE), D Costa, N Chaftar, V Barbot, C Imbert
PE44 Effect of fluoride on root dentin demineralization and biofilm composition using an in situ biofilm model
Glauber Campos Vale (BRAZIL), CPM Tabchoury, AA Del Bel Cury, LMA Tenuta, JM ten Cate, JA Cury
PE45 Lactobacillus brevis CD2 inhibits Prevotella melaninogenica biofilmClaudia Vuotto (ITALY), F Barbanti, P Mastrantonio, G Donelli
PE46 Application of Green Fluorecent Protein Reporter System in Streptococcus mutans for Study on Dual-Species BiofilmsXiaolan Li (CHINA), MA Hoogenkamp, J Ling, W Crielaard, D Deng
Tuesd
ay 10
Sep
temb
er
EUROBIOFILMS 2013 · 17
PE47 Do different cement types affect biofilm formation of implant-supported restorations?Silke-Mareike Marten (GERMANY), M Korsch, W Walther, U Obst
PE48 Effects of extract from potherb mustard on the biofilm formation of Actinomyces naeslundiiToshiaki Arai (JAPAN), T Kondho, N Ogura, Y Saeki, S Mohri, H Senpuku
PE49 The role of the regulatory protein ArcR in Streptococcus gordonii biofilm formationJill C Robinson (UNITED KINGDOM), N Jakubovics, M German, W Vollmer
PE50 Potential use of essential oils and surfactin on Streptococcus mutans biofilms.Ana Paula Resende Simiqueli (BRAZIL), VF Furletti, CA Breda, MCT Duarte, GM Pastore
PE51 Roles of Genes to Aggregation and Biofilm Formation in the Streptococcus mutansMizuho Motegi (JAPAN), H Yonezawa, H Senpuku
PE52 Proteins in the extracellular matrix of Fusobacterium nucleatum and Porphyromonas gingivalis biofilmMarwan Mansoor Ali Mohammed (NORWAY), Ah Nerland, V Bakken
PE53 Influence of mucin on the mechanical properties Streptococcus mutans biofilmsStefania Fabbri (UNITED KINGDOM), A Rmaile, D Carugo, L Capretto, M Ward, M Aspiras, P Stoodley
PE54 An Experimental and Computational Study of the Hydrodynamics of High-velocity Water Drops for the Inter-Dental CleaningAmir Rmaile (UNITED KINGDOM), D Carugo, L Capretto, X Zhang, Pj Thurner, Ja Wharton, M Aspiras, M Ward, P Stoodley
OTHER TOPICS
PE55 Human epithelial cell invasion of Aggregatibacter actinomycetemcomitans biofilm and planktonic cells
Jinfeng Zeng (THE NETHERLANDS), C Bosch-Thijhof, W Crielaard, DM Deng
PE56 Differential expression of Escherichia coli bacteriocin in aerobic and anaerobic biofilmsBihter Bayramoglu (ISRAEL), O Gillor
PE57 Biofilm Risk in Turkish Dairy IndustryDilvin Ýpek (TURKEY), NN Demirel Zorba
PE58 Modelling Wound Biofilms in a Thermo-Reversible Matrix with Fluorescent MarkersBenjamin Taylor (UNITED KINGDOM), D Williams, J Nosworthy
PE59 Dielectric barrier discharge atmospheric cold plasma for inactivation of bacterial biofilmsDana Ziuzina (IRELAND), S Patil, PJ Cullen, Paula Bourke
PE60 Adherence and biofilm formation by fimbriae mutants of a Klebsiella pneumoniae nosocomial isolateCA Ledezma-Escalante, Ma De la Cruz, JL Fernández-Vázquez, MD Jarillo-Quijada, C Gayosso-Vázquez, JI Santos-Preciado, J Girón, María Dolores Alcántar-Curiel (MEXICO)
PE61 Biofilm formation in 96-well microtiter plates under different hydrodynamic conditionsJoana Moreira (PORTUGAL), L Gomes, M Simões, L Melo, F Mergulhão
PE62 Semi-circular flow cells for biofouling simulationJ Teodosio, F Silva, J Moreira, M Simões, L Melo, M Alves, Filipe Mergulhao (PORTUGAL)
PE63 Optimisation of resazurin-based viability staining for quantification of microbial biofilmsFreija Van den Driessche (BELGIUM), G Brackman, T Coenye
Tues
day
10
Sep
tem
ber
18 · Ghent, Belgium, September 9-12, 2013
PE64 Studying nanoparticle transport: Towards improved treatment of chronic pulmonary infections in cystic fibrosisKatrien Forier (BELGIUM), A-S Messiaen, M Risseeuw, S Van Calenbergh, H Deschout, K Raemdonck, F De Baets, H Nelis, S De Smedt, J Demeester,T Coenye, K Braeckmans
PE65 Identification of small RNAs expressed in Burkholderia cenocepacia biofilms using differential RNA sequencingAndrea M Sass (BELGIUM), H van Acker, Ku Förstner, J Vogel, T Coenye
PE66 Biofilm formation is not correlated to phosphorylcholine content in clinical isolates of non-typeable Haemophilus influenzae
Carmen Puig (SPAIN), S Martí, PWM Hermans, C Ardanuy, J Liñares, JD Langereis
PE67 Adhesion and biofilm formation by non-typeable Haemophilus influenzae isolated from patients with Pneumonia, Chronic Obstructive Pulmonary Disease and healthy carriersCarmen Puig (SPAIN), A Domenech, P Mayer, C Ardanuy, J Liñares, S Marti
PE68 lysis buffer properties: influence on S. epidermidis biofilm proteome analysisVirginia Carvalhais (PORTUGAL), N Cerca, R Vitorino
PE69 Genotypic and phenotypic differences between nosocomial and commensal Staphylococcus epidermidis isolates from northern Portugal
Ana Isabel Freitas (PORTUGAL), F Oliveira, H Ramos, C Vasconcelos, M Vilanova, N Cerca
PE70 Biofilm formation by clinical isolates of Neisseria gonorrheaLiselotte Hardy (BELGIUM), S Abdellati, T Crucitti
PE71 Novel fungal exoproducts for biofilm destabilization in technical systemsTanja Kleintschek (GERMANY), H-G Lemaire, U Obst, T Schwartz
PE72 Novel microfluidic multichannel biosensor for online monitoring of biofilm formation and activity via electrochemical impedance spectroscopy and amperometryJulia Bruchmann (GERMANY), T Kleintschek, K Sachsenheimer, L Pires, T Schwartz, B Rapp
PE73 Interfering with small non-coding RNAs that regulate biofilm formationElke Van Assche (BELGIUM), H Steenackers, J Vanderleyden
PE74 A GFP promoter fusion library for the study of Salmonella biofilm formation and the mode of action of biofilm inhibitors
Stijn Robijns (BELGIUM), S Roberfroid, B De Pauw, A De Weerdt, D De Coster, S De Keersmaecker, J Vanderleyden, Hans Steenackers
PE75 Identification and development of novel broadly applicable anti-biofilm agents by using an integrated platform
Hans Steenackers (BELGIUM), Stijn Robijns, A De Weerdt, D Ermolat’ev, E Van der Eycken, P Chaltin, A Marchand, B Landuyt, M De Maeyer, K Marchal, J Vanderleyden
PE76 How marine bacteria adhere to inert surfaces?Perrine Van Overtvelt (FRANCE), C Bressy, Y Blache, M Molmeret
PE77 Biofilm building capacity of Salmonella and Campylobacter strains from the poultry production chainEsther Schonewille (GERMANY), L Nesse, R Hauck, D Windhorst, Hm Hafez, L Vestby
PE78 Profiling the type II and type vI secretion related extracellular proteome in Burkholderia Cenocepacia biofilms
Agata Goza (BELGIUM), T Coenye, M Valvano, B Devreese
Tuesd
ay 10
Sep
temb
er
EUROBIOFILMS 2013 · 19
PE79 Toward High-Resolution Chemical Imaging of Biofilms: Integration of Synchrotron Imaging and Electron MicroscopyMatthew Marshall (UNITED STATES OF AMERICA), S Belchik, M Thomas, L Kucek, E Hill, A Winschell, A Dohnalkova, C Szymanski, S Kabilan, J Carson, E Miller, C Hirschmugl
PE80 Aeromonas punctata derived depolymerase vs a phage borne depolymerase against Klebsiella pneumoniae K2 capsule: A comparative studyShruti Bansal (INDIA), K Harjai, S Chhibber
PE81 Halophilic microorganisms as a source of novel antibiofilm compoundsJulianne Megaw (UNITED KINGDOM), A Busetti, C Maggs, B Gilmore
PE82 Microscopic Examination of Biofilm Destruction by Atmospheric Pressure PlasmaMahmoud Alkawareek (UNITED KINGDOM), S Gorman, W Graham, B Gilmore
PE83 Biofilm Disruption and Synergistic Antimicrobial Effects of a Novel Alginate Oligomer on Pseudomonas aeruginosa In vitro and In vivo
Wang Hengzhuang (DENMARK), Z Song, O Ciofu, E Onsøyen, P Rye, N Høiby
PE84 Antibiofilm activity of the Antarctic Pseudoalteromonas haloplanktisRosanna Papa (ITALY), M Artini, M Tilotta, F Sannino, S Carillo, M Corsaro, Ml Tutino, L Selan, E Parrilli
PE85 Biofilm as a source of new anti-biofilm compoundsMarco Tilotta (ITALY), R Papa, A Cellini, A Servello, C Genovese, L Selan, M Artini
PE86 In vitro activity of the CecropinA-Melittin analogues CM12 and CM18 against biofilm-forming Staphylococcus epidermidisMariagrazia Di Luca (ITALY), F Cardarelli, F Salomone, G Maccari, C Boccardi, G Signore, R Bizzarri
PE87 Fluorescent microscopy of clinical biofilm infections - a cautionary tale of false positivesSteffen Eickhardt (DENMARK), K Kragh, N Høiby, T Bjarnsholt, M Alhede
PE88 Plasmid transfer in biofilms from a food industry perspectiveEva Van Meervenne (BELGIUM), E Van Coillie, F Devlieghere, L Herman, N Boon
PE89 Enterococcus faecium biofilm formation: identification of major autolysin AtlAEfm, associated Acm surface localization and AtlAEfm-independent eDNA releaseFernanda Paganelli (THE NETHERLANDS), R Willems, P Jansen, A Hendrickx, X Zhang, M Bonten, H Leavis
PE90 Role of adhesive structures in the interaction processes of Shiga toxin-producing Escherichia coli on abiotic and biotic surfacesCecilia Matheus-Guimarães (BRAZIL), Cm Abe, Sf Sampaio, Tat Gomes, Bec Guth
PE91 Biofilm formation by virulent and non-virulent strains of Haemophilus parasuisMario Jacques (CANADA), V Aragon, V Deslandes, B Bello-Ortí, J Labrie
PE92 In-situ Determination of the Mechanical Properties of Gliding or Non-Motile Bacteria by Atomic Force Microscopy under Physiological Conditions.Christian Marlière (FRANCE), S Dhahri
PE93 Effects of Epigallocatechin-3-gallate (EGCg) in Comparison to Colistin and Tobramycin on Young and Mature Biofilms of Mucoid Pseudomonas aeruginosa IsolatesPedrina Goncalves Vidigal (GERMANY), S Dittmer, J Buer, P-M Rath, J Steinmann
PE94 Quantification of micro-organisms by flow cytometry using TO-PRO®-3Monique Kerstens (BELGIUM), G Boulet, I Pintelon, M Hellings, L Voeten, P Delputte, L Maes, P Cos
PE95 Bile Salts-Induced Biofilm Formation by Enterococcus faeciumK Meredith, Albert Bolhuis (UNITED KINGDOM)
Tues
day
10
Sep
tem
ber
20 · Ghent, Belgium, September 9-12, 2013
PE96 Exploring the Capacity of Metals for Treating Biofilm InfectionsJoseph Lemire (CANADA), A Bradu, L Kalan, RJ Turner
PE97 An Easy, Cheap and Reproducible Biofilm Setup for Fast Screening of Different Biofilm Phenotypes
Camilla Stavnsbjerg (DENMARK), AK Nielsen, N Høiby, M Alhede
PE98 Alginate encapsulated Pseudomonas aeruginosa - a novel in vitro biofilm modelMajken Sønderholm (DENMARK), M. Alhede, M. Alhede, L. Behrendt, M. Kühl, T. Bjarnsholt
PE99 Imaging of in vivo biofilm developing on silicone implants and the interplay with PMNsMaria Alhede (DENMARK), M Alhede, K Qvortrup, T Bjarnsholt
PE100 Biofilm Associated Genes in Mastitis Pathogen Streptococcus uberisTiina Salomäki (FINLAND), J Reunanen, A Iivanainen, P Varmanen
PE101 The Assessment of Potential Biofilm-Disrupting Technologies in vitroLouise Suleman (UNITED KINGDOM), Pd Clegg, Ca Cochrane, J Nosworthy
PE102 Surfactin reduces the adhesion of Salmonella Enteritidis to polystyreneM Gomes, Marcia Nitschke (BRAZIL)
PE103 High resolution multiple-stage linear ion-trap mass spectrometry towards total structural analysis of the apolar mycolic acid-containing lipids that contribute to biofilm formation in
Mycobacterium smegmatisFong-Fu Hsu (UNITED STATES OF AMERICA), GE Purdy
PE104 The challenges of discovering new anti-biofilm probes and leads from a high-throughput screening perspective
Adyary Fallarero (FINLAND), M Skogman, V Moreira, S Manner, D Ausbacher, R Leino, M Strøm, J Yli-Kauhaluoma, P Vuorela
PE105 Exploring flavonoids, the extensively known natural compounds class, for anti-biofilm effects utilizing high throughput screening and in silico modelingS Manner, M Skogman, P Vuorela, Adyary Fallarero (FINLAND)
PE106 In-vitro the effect of Staphylococcus aureus biofilm by BaicalinJin-Liang Kong (CHINA), YY Huang, YQ Chen, Y Chen, P Yan, SQ Cai, ZU Du
PE107 Biofilm formation in invasive Staphylococcus aureus isolates is associated with spa-CC 064 and MlST CC5Preneshni Naicker (SOUTH AFRICA), K Karayem, K Hoek, E Wasserman
POSTER SESSION 02 - WEDNESDAY 11 SEPTEMBER, 13:00 – 15:00
Parallel session 05 - Heterogeneity and evolution in biofilms
PE108 Experimental evolution: an approach to understand the mode of action of a biofilm inhibitorAkanksha Dubey (BELGIUM), A Sanchez, K Marchal, J Vanderleyden, H Steenackers
PE109 Heterogonous transcription of genetic elements in biofilm of Salmonella in response to different stress conditionsDov Schlisselberg (ISRAEL), S Yaron
PE110 Protease secretion of Staphylococcus epidermidis and the effect of S. epidermidis supernatant on Staphylococcus aureus biofilmsIlse Vandecandelaere (BELGIUM), P Depuydt, H Nelis, T Coenye
Wed
nesd
ay 11
Sep
temb
erTu
esday 1
0 S
eptem
ber
EUROBIOFILMS 2013 · 21
PE111 Biofilm Competition and Coexistence – a dual species biofilm modelSaravanan Periasamy (SINGAPORE), K Kai Wei Lee, M Mukherjee, H A.S. Nair, S Kjelleberg, S Rice
PE112 Synergistic interactions within polymicrobial biofilms formed by atypical and conventional species in cystic fibrosis
Susana Patrícia Peixoto Lopes (PORTUGAL), NF Azevedo, MO Pereira
PE113 Frequent transcriptional switching of the cell wall adhesion gene, FlO11, mediates social behavior in yeast biofilm
Kristian Hanghøj (DENMARK), K Andersen, B Regenberg
PE114 Evolution and composition of biofilms in cooling lubricant systemsJennifer Edith Langbein (GERMANY), A Spielvogel, U Stahl, D Oberschmidt, E Uhlmann
PE115 Unraveling gene expression profiles in mono- and multispecies Salmonella Typhimurium biofilmsStefanie Roberfroid (BELGIUM), K Hermans, T Verhoeven, J Vanderleyden, SCJ De Keersmaecker, HPL Steenackers
PE116 A yeast amino acid transporter is essential for biofilm and can flip a bet-hedging switch, enabling adaptation to diverse environmentsHenrik Devitt Møller (DENMARK), R Torbensen, D Gresham, S New York University, D Ochmann, E Boles, B Regenberg
PE117 Characterization of spatial structures in biofilms of three strains of L.monocytogenesMaruxa Mosquera Fernández (SPAIN) M Lopez Cabo, E Balasa Canto
PARAllEl SESSION 06 - MEDICAl DEvICE-RElATED BIOFIlM INFECTIONS AND MODIFIED MATERIAlS PE118 COATIM – Development of antibiofilm coatings for implants
Katrijn De Brucker (BELGIUM), BPA Cammue, J Michiels, J Vanderleyden, P Van Dijck, J Vleugels, T Bernardi, M Erdtmann, F Impellizeri, J Kovac, M Fröhlich, A Krona, G Majdic, A O’Neill, K Thevissen
PE119 Bacterial biofilm formation and treatment in soft tissue fillersMorten Alhede (DENMARK), Ö Er, S Eickhardt, K Kragh, M Alhede, L Christensen, S Poulsen, L Christensen, N Høiby, M Givskov, M Tvede, T Bjarnsholt
PE120 Interaction between non-disease causing microorganism and E. coli in catheter-associated urinary tract biofilmsAndreia Azevedo (PORTUGAL), C Almeida, L de Melo, NF Azevedo
PE121 Polymicrobial biofilm dynamics during catheter-associated urinary tract infectionsSharon Goh (SINGAPORE), V Lai, J Chua, S Chen, K Kline
PE122 Improving the diagnostic of prosthetic joint infections– a multidisciplinary clinical studyTrine Rolighed Thomsen (DENMARK), LH Larsen, MH Kyneb, Y Xu, J Lorenzen, O Simonsen, S Rasmussen, H Schønheyder, PRIS study group
PE123 Chronic prosthesis joint infection - Case reportLone Heimann Larsen (DENMARK), M Frost, R Aleksyniene, A Kappel, V Khalid, HC Schønheyder, TR Thomsen, PRIS study group ,
PE124 A murine model of antibiotic treatment of Staphylococcus aureus biofilm implant associated osteomylitis
Nis Jørgensen (DENMARK), RL Meyer, F Dagnæs-Hansen, K Fuursted, E Petersen
PE125 Comparison of the roll-plate , sonication and vortexing techniques in biofilm removal of intravascular catheter colonization: results of a prospective randomised study.
Stergiani Arampatzi (GREECE), A Trampuz, E Protonotariou, G Giannoglou, O Borens, M Arampatzi, E Diza
Wed
nes
day
11
Sep
tem
ber
22 · Ghent, Belgium, September 9-12, 2013
PE126 Towards improving the diagnosis of biofilm associated prosthetic joint infection by sonication of Polymethylmethacrylate (PMMA) cementHerbert Gbejuade (UNITED KINGDOM), J Webb, A Hidalgo-Arroyo, J Leeming, A Lovering
PE127 Antimicrobial activities of daptomycin, vancomycin and gentamicin loaded polymethylmethacrylate (PMMA) cement on Staphylococcus epidermidis biofilm: an experimental
model of a joint infection.Herbert Gbejuade (UNITED KINGDOM), A Lovering, A Hidalgo-Arroyo, J Webb
PE128 Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model
Qi Lu (CHINA), J Yu, T Ran
PE129 Antifouling polyurethanes to fight medical device-related infectionsI Francolini, Fa Baroncini, Gianfranco Donelli (ITALY), P Stoodley, C Vuotto, V Taresco, A Martinelli, L D’Ilario, A Piozzi
PE130 The Prevalence of Biofilm Formation Among Enteroccoccus faecalis Clinical Isolates and Comparison of Urinary Catheters to Inhibit the Biofilms
Didem Kart (TURKEY), As Kustimur, M Özalp, A Kalkancý
PE131 In vitro evaluation of silver-coated silicone on growth and attachment of clinical isolates from patients with tracheobronchial stentsSara Marti (SPAIN), L Calatayud, J Gilabert, C Ardanuy, S Borrós, R López-Lisbona, N Cubero, A Rosell, J Linares
PE132 Disruptive effects of adhesive agents on Biofilm-Forming Microorganisms in vitroEleri M Jones (UNITED KINGDOM), PD Clegg, JA Hunt, SL Percival, CA Cochrane
PE133 Impact of surface roughness on biofilm formation of Klebsiella pneumoniae and Staphylococcus aureusIrene Müller (GERMANY), Stanislav N. Gorb, Ruth A. Schmitz-Streit
PE134 Staphylococcus epidermidis lPXTG surface protein SesC is an ideal anti-biofilm vaccine targetMohammad Shahrooei (BELGIUM), L Khodaparast, L Khodaparast, J Van Eldere
PE135 Antibiofilm activity of the Brown Macroalga Halidrys siliquosaAlessandro Busetti (UNITED KINGDOM), M Alkawareek, J Megaw, C Maggs, B Gilmore
PE136 Sortase inhibition – an anti-biofilm strategy in StreptococciGeorge Shaw (UNITED KINGDOM), B Gilmore, A McCloskey
PE137 Non-Thermal Plasma for Control of P. aeruginosa Biofilms: Effect of Biofilm Components on Tolerance
Nid’a Alshraiedeh (UNITED KINGDOM), MY Alkawareek, SP Gorman, WG Graham, RP Ryan, BF Gilmore
PE138 Pseudomonas aeruginosa Biofilm (BF) Adhesion and Dispersion on lenses under Ketorolac (Kl) Influence: in vitro studyMarisa Arcos (ARGENTINA), A Farinati, M Santanlucia, T Di Luca
PE139 Biofilms and Wounds: Evidence so far!Rebecca Booth (UNITED KINGDOM), Emma Woods, Steven Percival
PE140 Biofilm Management in WoundcareSteven Percival (UNITED KINGDOM), Rebecca Booth, Emma Woods
PE141 Adhesives and Their Role in Biofilm PreventionSteven Percival (UNITED KINGDOM), Rebecca Booth, Emma Woods
Wed
nesd
ay 11
Sep
temb
er
EUROBIOFILMS 2013 · 23
PE142 Characteristics of P. aeruginosa and S. aureus grown in agar versus poloxamerEmma Woods (UNITED KINGDOM), Rebecca Booth, Steven Percival
PE143 In vitro Characterisation of Resistant BiofilmsEmma Woods (UNITED KINGDOM), Rebecca Booth, Steven Percival
PE144 The use of the MBEC assay for quantitative and qualitative investigation of biofilm forming capacity of wound isolated bacteria
Rebecca Booth (UNITED KINGDOM), Emma Woods, Steven Percival
PE145 Evaluation of the ability of antimicrobial molecules to prevent biofilm formation on titanium implant materials using ClSM
Maria Lövenklev (SWEDEN), A Krona
PE146 Application of Flow-Through Isothermal Microcalorimetry to the Study of Microbial Biofilms on Medical DevicesJawal F.S. Said (UNITED KINGDOM), PD Stapleton, AE Beezer, S Gaisford
PE147 Intraspecies varation in Staphylococcus epidermidis adhesion onto coated and uncoated hydrophobic materials
Thomas Vanzieleghem (BELGIUM), C Nannan, M Thiel, P Herman, Y Dufrêne, C Dupont, J Mahillon
PE148 New models for the study of Staphylococcal biofilms on cathetersMarian Van kerckhoven (BELGIUM), I Pintelon, G Boulet, P Delputte, P Cos, L Maes
PE149 Biofilm killing by wound dressings containing silver, iodine and diacetateAnne Kirstine Nielsen (DENMARK), K Kirketerp-Møller, T Bjarnsholt, M Alhede
PE150 Whole transcriptome analysis of Staphylococcus epidermidis biofilms upon contact with human bloodAngela França (PORTUGAL), V Carvalhais, T Maira-Litrán, M Vilanova, N Cerca, G Pier
PE151 Immobilisation of Cellobiose Dehydrogenase as an antibiofilm agent on silicon cathetersBarbara Thallinger (AUSTRIA), C Sygmund, R Ludwig, M Brandauer, A Schlick, GS Nyanhongo, GM Gübitz
PE152 Covalently-Bound Thiophenone inhibits Biofilm Formation on Implant SurfacesAli-Oddin Naemi (NORWAY), T Benneche, FK Hansen, AA Scheie
PARAllEl SESSION 07 - FUNDAMENTAl ASPECTS OF FUNGAl BIOFIlM FORMATION AND RESISTANCE
PE153 Transcriptional Regulation of Candida albicans Biofilm Development Over TimeEmily Fox (UNITED STATES OF AMERICA), C Nobile, M Mui, A Johnson
PE154 Antifungal activity of cathelicidin peptides against planktonic cultures and biofilms of pathogenic Candida species.Michele Scarsini (ITALY), L Tomasinsig, B Skerlavaj, A Arzese, M Zanetti
PE155 Effect of alkylphospholipids on Candida spp. biofilm formation and maturationTaissa Vila (BRAZIL), K Ishida, W de Souza, KP Prousis, T Calogeropoulou, S Rozental
PE156 Anidulafungin (ANF) activity in vitro on urogenital Candida spp biofilms (BF)Alicia Farinati (ARGENTINA), M Marques, G Santiso, M Arcos
PE157 Identification of genes involved in Saccharomyces cerevisiae biofilm development by screening of a complete gene deletion library.Kaj S Andersen (DENMARK), O Ryan, Mw Nielsen, Rk Bojsen, A Folkesson, B Regenberg
Wed
nes
day
11
Sep
tem
ber
24 · Ghent, Belgium, September 9-12, 2013
PARAllEl SESSION 08 - ECOlOGY OF AQUATIC BIOFIlMS PE158 Bacterial diversity of biofilms in UK drinking water networks: implications for water quality
Isabel Douterelo (UNITED KINGDOM), S Husband, J Boxall
PE159 Passage through amoeba induces Legionella pneumophila biofilm productionRenaud Bigot (FRANCE), J Bertaux, J Frere, J-M Berjeaud
PE160 Extracellular DNA in aquatic biofilms: A universal adhesinRikke Louise Meyer (DENMARK), L Tang, VR Regina, G Zeng, Rr Neu, A Schramm, A Lokanathan, D Sutherland
PE161 Biofouling of reverse osmosis membranes after tertiary wastewater desalination: Microbial community composition
Ashraf Ashhab (ISRAEL), M Herzberg, O Gillor
PE162 Improvements on disinfection practices for Legionella control in cooling tower waterCarla Denis (BELGIUM), P Schook, J Rajan, L Vanysacker, P Declerck
PE163 Characterization of biofilm formed by vibrio tapetis, the causative agent of Brown Ring DiseaseSophie Rodrigues (FRANCE), A Dufour, C Paillard, A Bazire
PE164 Improving larvae rearing of the marine fish Amphiprion ocellaris (A. ocellaris) by beneficial biofilms
Wiebke Hansen (GERMANY), P Kegler, S Kroll, A Kunzmann, S Neumann, B Ramsch, B Sellner, C Soltmann, S Wittka,K Rezwan, M Lohmeyer
PE165 Antibiofilm activity of an exopolysaccharide from the marine invasive sponge Celtodoryx ciocalyptoides
Charline Gentric (FRANCE), P Sauleau
PARAllEl SESSION 09 - INDIRECT PATHOGENICITY AND THE ROlE OF MIXED SPECIES BIOFIlMS IN INFECTIONS
PE166 Use of an in vitro gut model to study biofilm mode of growth of C. difficile and indigenous gut microbiotaGrace Crowther (UNITED KINGDOM), C Chilton, S Todhunter, S Nicholson, M Wilcox
PE167 Polymicrobial interactions in multispecies biofilms of cystic fibrosis pathogens, Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cenocepacia, in drip flow reactor
Indra Sandal (UNITED STATES OF AMERICA), S Annadata, G James
PE168 Phagocytosis of Candida albicans-adhered Staphylococcus aureusNina Scheres (THE NETHERLANDS), B Krom
PE169 Exploring the influence of Candida albicans and Staphylococcus aureus on the resistance of Pseudomonas aeruginosa biofilms towards disinfectants and antibiotics
Sarah Tavernier (BELGIUM), D Kart, H Nelis, T Coenye
PE170 Biofilm Dispersal - Bench to BedsideR Howlin, K Cathie, L Hall-Stoodley, G Connett, J Legg, S Kjelleberg, M Kelso, N Barraud, S Rice P Stoodley S Faust Jeremy Webb (UNITED KINGDOM),
PE171 Mixed biofilms of Klebsiella pneumoniae and Pseudomonas aeruginosa ‘HACKED’Shruti Bansal (INDIA), S Kaur, S Chhibber
PE172 Denitrification by Cystic Fibrosis PathogensMette Kolpen (DENMARK), T Bjarnsholt, C R. Hansen, C S. Dalbøge, M Kuhl, N Høiby, P Ø. Jensen
Wed
nesd
ay 11
Sep
temb
er
EUROBIOFILMS 2013 · 25
PE173 vaginal biofilm (vBF) dynamic from normal to the endogenous infections: in vitro study in sexually active women (SAW)
Alicia Farinati (ARGENTINA), M Marques, A Orsini, M Arcos
PE174 Candida albicans - Pseudomonas aeruginosa mixed biofilms in the context of dental unit waterlines
Damien Costa (FRANCE), V Barbot, B Fernandez, J Verdon, C Imbert
PE175 Supernatant from a Staphylococcus aureus overnight culture mediates killing of Pseudomonas aeruginosa biofilmStephanie Geisler Crone (DENMARK), M Alhede, M Alhede, T Bjarnsholt
PE176 Clinically relevant polyculture biofilm produces protective environments for the development of resistancePhilip Skipper (UNITED KINGDOM), A Gillet, R Dixon
PE177 Isolation of Gardnerella vaginalis from Bv patients and healthy women: analysis of virulence through adherence, biofilm formation and cytotoxicity assaysJoana Castro (PORTUGAL), P Alves, C Sousa, T Cereija, N Cerca
PE178 Gardnerella vaginalis virulence potential outcompetes with 30 other microorganisms isolated from Bv patientsP Alves, J Castro, C Sousa, T Cereija, Nuno Cerca (PORTUGAL)
PE179 Influence Of low-Dose Nitric Oxide On Polymicrobial Communities Derived From Cystic Fibrosis SputumCaroline Duignan (UNITED KINGDOM), R Howlin, L Hall-Stoodley, P Stoodley, T Daniels, M Carroll, S Clarke, S Faust, J Webb
PARAllEl SESSION 10 - BIOFIlMS PUT TO WORK: APPlICATION OF MICROBIAl BIOFIlMS IN vARIOUS PROCESSES
PE180 Effect of Electrochemical Potential on Biosynthesis of Silver Nanoparticles in Shewanella oneidensis MR-1 Biofilm
Michael Kitching (IRELAND), C Kiat, B Cao, E Marsili
PE181 Cross-species metabolism of natural dissolved organic carbon enhances the synergistic removal of xenobioticsBenjamin Horemans (BELGIUM), J Vandermaesen, P Breugelmans, E Smolders, D Springael
PE182 Harnessing oil sands microbes as biofilms for bioremediationMarc Demeter (CANADA), J Lemire, G Yue, I George, H Ceri, RJ Turner
PE183 Effect of Bacteria on Pre-formed and Nascent Biofilms of Irpex lacteusCenek Novotny (CZECH REPUBLIC), M Plackova, S Montalvao, H Mikeskova, K Malachova, JA Teixeira
PE184 Invading biofilms. The access code to successful bioaugmentation for treating drinking waterBenjamin Horemans (BELGIUM), A Sekhar, J Vandermaesen, D Springael
PE185 Populating Biofilm Support Materials for Oilsands Tailings RemediationJoseph Lemire (CANADA), M Demeter, C Stremick, J Song, H Ceri, RJ Turner
PE186 Exploring the molecular mechanisms of aggregation in cyanobacteriaEsther Karunakaran (UNITED KINGDOM), J de Vries, H van der Mei, C Biggs
PE187 Enhanced biological nitrogen removal in contaminated source water remediation systemLiang Zhu (CHINA), L Feng, X Xu
Wed
nes
day
11
Sep
tem
ber
26 · Ghent, Belgium, September 9-12, 2013
PARAllEl SESSION 11 - FINAl jOINT SYMPOSIUM : SIGNAllING IN MICROBIAl BIOFIlMS : C-DI-GMP, QUORUM SENSING AND BEYOND
PE188 Tampering with purine and pyrimidine biosynthesis modulates biofilm formation of Escherichia coli and SalmonellaAnna Yssel (BELGIUM), E Peeters, S Robijns, A De Weerdt, J Vanderleyden, H Steenackers
PE189 Are Amyloids the Information Superhighways of Biofilms?Thomas Seviour (SINGAPORE), S Geifman Shochat, S Kjelleberg, M Dueholm, S Hove Jensen
PE190 DSF family signal molecules found in the cystic fibrosis airway modulate biofilm formation and antibiotic tolerance in Pseudomonas aeruginosaKate B Twomey (IRELAND), Y McCarthy, JM Dow, BJ Plant, RP Ryan
PE191 Dispersion Induced by Cell-to-Cell Communication Signaling Molecule in Pseudomonas aeruginosa Biofilm
Satoshi Ito (JAPAN), K Kakihara, M Toyofuku, T Nakajima, H Uchiyama, N Nomura
PE192 Milk constituents trigger biofilm formation of Bacillus subtilis via activation of the tapA operonMoshe Shemesh (ISRAEL), R Pasvolsky-Gutman, V Zakin
PE193 Do bacteria that exhibit quorum sensing inhibitory properties affect biofilm formation and virulence in P. aeruginosa PAO-1?
Steven Christiaen (BELGIUM), H Nelis, T Coenye
PE194 Modified dressings to interfere with biofilm formation and quorum sensing in chronically infected wounds
Gilles Brackman (BELGIUM), MJ Garcia-Fernandez, C Alvarez-Lorenzo, A Concheiro, H Nelis, T Coenye
PE195 validation of PqsD as anti-biofilm target in Pseudomonas aeruginosaChristine Katharina Maurer (GERMANY), MP Storz, C Brengel, E Weidel, C Zimmer, M Müsken, S Häussler, A Steinbach, RW Hartmann
PE196 Indian spices as modulators of quorum sensing in Cronobacter sakazakii, a food borne pathogenNiharika Singh (INDIA), G Goel, M Raghav, CS Rajani, A Puniya
PE197 Escherichia coli colonization on a solid surface based on the expression of flagellum and curliMinh Hong Nguyen (JAPAN), Y Ojima, M Taya
PE198 Quorum sensing is needed for Rhodospirillum rubrum cell dispersionSandra Condori (BELGIUM), N Leys, R Wattiez, F Mastroleo
PE199 Evaluation for antibiofilm activity of new homoserine lactones (HSl) analogs of Pseudomonas aeruginosaAurélie Furiga Chusseau (FRANCE), B Lajoie, S El Hage, G Baziard, C Roques
PE200 The identification of biofilm virulence factors using differential proteome analysis (SIlAC and lC-MS)Joke Donné (BELGIUM), G Boulet, P Cos, L Maes, S Dewilde
PE201 RsmA controls biofilm formation in Xanthomonas campestris through a complex system involving cyclic di-GMP and the Clp transcription factor
Shi-Qi An (UNITED KINGDOM), Y McCarthy, J Dow, R Ryan
PE202 Thiophenone interferes with AI-2 stimulated quorum sensing in Escherichia coliIngun Lund Witsø (NORWAY), H Valen Rukke, T Benneche, A Aamdal Scheie
PE203 Aerobic Cbb3-type Cytochrome c Oxidase Promotes Aggregate Formation of Pseudomonas aeruginosa under Anaerobic Denitrifying Environments, via Nitric Oxide Signal
Masakaze Hamada (JAPAN), M Toyofuku, T Miyano, T Nakajima-Kambe, H Uchiyama, N Nomura
PE204 Indole Compounds Control Biofilm Formation and Pathogenesis in Diverse BacteriaJintae Lee (KOREA)
Wed
nesd
ay 11
Sep
temb
er
Notes
AV INFORMATION FOR YOUR PRESENTATION AT THE 21ST ECCMID/27TH ICC
Important points in brief:
We would like to inform you that each meeting room will be equipped with a PC and a data projector for PowerPoint presentations only. You can review your presentation at the speakers service centre (SSC), where it must be handed in at least one hour before your lecture, either via External Hard Disk, CD-Rom, memory stick, or your own laptop.
Further details and hints for computer based projections: 1. Preparation Store ALL your files in a unique folder (especially videos) Avoid animations and make sure video(s) play automatically when slide is displayed Colours: use light-coloured fonts for texts (white/yellow) on dark backgrounds or vice versa. A
strong contrast is important for good legibility Legibility check: step back 1,5 m from your computer, the text should be easily readable on
presentation mode (if not, you are using a too small font!) PowerPoint & Windows Versions from 95 to 2003 may be used
2. How to transport your MS-PowerPoint file to the Speakers Service Centre (SSC) On CD-Rom, External Hard Disk, memory stick or your own laptop
3. In the Speakers Service Centre (SSC) Please come to the SSC the day before or at least one hour before your lecture! Hostesses will be happy to welcome you in a relaxed and friendly atmosphere to help you
submit/finalise your presentation Highly experienced and skilled technicians will capture your presentation and store it on a server You then rehearse your presentation with the assistance of a technician Technicians will help you with PowerPoint and will ensure that your changes are updated on the
specific server 4. In the lecture room Via network your presentation is made available in your lecture room, on a presentation computer
operated by a technician With a touch-screen control at the lectern you can simply "ask" for the "next slide" or "previous
slide" There will be no possibility to connect your laptop at the lectern in the lecture rooms No overhead or slide projectors in the lecture rooms; no double projection No change in presentation in the lecture room by the technician or the speaker
Organised and supported by European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Des
ign
by K
andr
ups
Bogt
rykk
eri A
/S